Thus, while RASD1 downregulation may be a common feature of these cancers, its functional relevance appears to be context-dependent, emphasizing the need for further studies to elucidate the underlying mechanisms governing its differential impact on cancer prognosis. This evidence concerns the gene RASD1 and cancer.